|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 29528 |
FusionGeneSummary for PTPRJ_TAF3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PTPRJ_TAF3 | Fusion gene ID: 29528 | Hgene | Tgene | Gene symbol | PTPRJ | TAF3 | Gene ID | 5795 | 83860 |
| Gene name | protein tyrosine phosphatase, receptor type J | TATA-box binding protein associated factor 3 | |
| Synonyms | CD148|DEP1|HPTPeta|R-PTP-ETA|SCC1 | TAF140|TAFII-140|TAFII140 | |
| Cytomap | 11p11.2 | 10p14 | |
| Type of gene | protein-coding | protein-coding | |
| Description | receptor-type tyrosine-protein phosphatase etaCD148 antigenDEP-1HPTP etaR-PTP-Jdensity-enhanced phosphatase 1human density enhanced phosphatase-1protein tyrosine phosphatase, receptor type, J polypeptideprotein-tyrosine phosphatase etasusceptibil | transcription initiation factor TFIID subunit 3140 kDa TATA box-binding protein-associated factorRNA polymerase II transcription factor TAFII140TAF(II)140TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDaTBP-associated f | |
| Modification date | 20180522 | 20180522 | |
| UniProtAcc | Q12913 | Q5VWG9 | |
| Ensembl transtripts involved in fusion gene | ENST00000418331, ENST00000440289, ENST00000526550, | ENST00000344293, | |
| Fusion gene scores | * DoF score | 6 X 6 X 5=180 | 6 X 3 X 5=90 |
| # samples | 7 | 6 | |
| ** MAII score | log2(7/180*10)=-1.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/90*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: PTPRJ [Title/Abstract] AND TAF3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | PTPRJ | GO:0008285 | negative regulation of cell proliferation | 14709717|16682945|16778204 |
| Hgene | PTPRJ | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 14709717 |
| Hgene | PTPRJ | GO:0030308 | negative regulation of cell growth | 14709717 |
| Hgene | PTPRJ | GO:0030336 | negative regulation of cell migration | 16682945 |
| Hgene | PTPRJ | GO:0035335 | peptidyl-tyrosine dephosphorylation | 9531590|10821867|12913111|16778204|18348712|18936167|19332538 |
| Hgene | PTPRJ | GO:0043116 | negative regulation of vascular permeability | 19332538 |
| Hgene | PTPRJ | GO:0043407 | negative regulation of MAP kinase activity | 19494114 |
| Hgene | PTPRJ | GO:0050860 | negative regulation of T cell receptor signaling pathway | 12913111 |
| Hgene | PTPRJ | GO:0050918 | positive chemotaxis | 14709717 |
| Tgene | TAF3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 18549481 |
| Tgene | TAF3 | GO:0043433 | negative regulation of DNA binding transcription factor activity | 18549481 |
| Tgene | TAF3 | GO:0051457 | maintenance of protein location in nucleus | 15870280 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | OV | TCGA-10-0928-01A | PTPRJ | chr11 | 48177671 | + | TAF3 | chr10 | 8005883 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000418331 | ENST00000344293 | PTPRJ | chr11 | 48177671 | + | TAF3 | chr10 | 8005883 | + |
| intron-3CDS | ENST00000440289 | ENST00000344293 | PTPRJ | chr11 | 48177671 | + | TAF3 | chr10 | 8005883 | + |
| intron-3CDS | ENST00000526550 | ENST00000344293 | PTPRJ | chr11 | 48177671 | + | TAF3 | chr10 | 8005883 | + |
Top |
FusionProtFeatures for PTPRJ_TAF3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PTPRJ | TAF3 |
| Tyrosine phosphatase which dephosphorylates orcontributes to the dephosphorylation of CTNND1, FLT3, PDGFRB, MET,RET (variant MEN2A), KDR, LYN, SRC, MAPK1, MAPK3, EGFR, TJP1,OCLN, PIK3R1 and PIK3R2. Plays a role in cell adhesion, migration,proliferation and differentiation. Involved in vasculardevelopment. Regulator of macrophage adhesion and spreading.Positively affects cell-matrix adhesion. Positive regulator ofplatelet activation and thrombosis. Negative regulator of cellproliferation. Negative regulator of PDGF-stimulated cellmigration; through dephosphorylation of PDGFR. Positive regulatorof endothelial cell survival, as well as of VEGF-induced SRC andAKT activation; through KDR dephosphorylation. Negative regulatorof EGFR signaling pathway; through EGFR dephosphorylation.Enhances the barrier function of epithelial junctions duringreassembly. Negatively regulates T-cell receptor (TCR) signaling.Upon T-cell TCR activation, it is up-regulated and excluded fromthe immunological synapses, while upon T-cell-antigen presentingcells (APC) disengagement, it is no longer excluded and candephosphorylate PLCG1 and LAT to down-regulate prolongation ofsignaling. {ECO:0000269|PubMed:10821867,ECO:0000269|PubMed:11259588, ECO:0000269|PubMed:12062403,ECO:0000269|PubMed:12370829, ECO:0000269|PubMed:12475979,ECO:0000269|PubMed:12913111, ECO:0000269|PubMed:14709717,ECO:0000269|PubMed:16682945, ECO:0000269|PubMed:16778204,ECO:0000269|PubMed:18348712, ECO:0000269|PubMed:18936167,ECO:0000269|PubMed:19332538, ECO:0000269|PubMed:19494114,ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:19922411,ECO:0000269|PubMed:21091576, ECO:0000269|PubMed:21262971,ECO:0000269|PubMed:9531590, ECO:0000269|PubMed:9780142}. | Transcription factor TFIID is one of the general factorsrequired for accurate and regulated initiation by RNA polymeraseII. TFIID is a multimeric protein complex that plays a centralrole in mediating promoter responses to various activators andrepressors. Required in complex with TBPL2 for the differentiationof myoblasts into myocytes. The complex replaces TFIID at specificpromoters at an early stage in the differentiation process. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PTPRJ_TAF3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PTPRJ_TAF3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PTPRJ | CTNND1, CTNNB1, SDCBP, PLCG1, LAT, EGFR, GRB2, PTPRJ, FBXO6, LGALS3, LGALS8, LGALS9, BAP1, CASC3, CYP17A1, EPSTI1, HOXC6, KLK7, KLK9, LYPD3, PRDM14, TRIM25, CDH1, RINT1, C19orf25, NOS1AP, C1orf226, RAB11FIP1 | TAF3 | KHDRBS2, TAF10, TBP, TBPL2, KAT2A, TAF12, TAF13, SAP130, TAF7, CTCF, TAF5, TAF4, TAF6, TAF1, KPNA2, KPNB1, HIST3H3, HIST2H4A, MED26, NPM1, CDC23, NAP1L4, ANAPC10, CDC16, MZT1, TAF7L, TAF8, TAF11 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PTPRJ_TAF3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PTPRJ_TAF3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|